ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Puerto Rico » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IVAN AYALA M.D.

Cardiovascular Disease

42,693

$1.27M

1633
1430 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $36

JOSE PADILLA MD

Cardiovascular Disease

37,599

$1.4M

1658
1379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $36

JOSE RIVERA M.D.

Cardiovascular Disease

36,961

$1.51M

1430
1075 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $36

ADOLFO SANCHEZ ORTIZ M.D.

Cardiovascular Disease

31,191

$1.26M

1110
839 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $36

FRANCISCO GARCIA-CORTES M.D.

Cardiovascular Disease

31,138

$1.07M

1276
991 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $36

MARIA MARTI LON MD

Cardiovascular Disease

29,598

$883K

837
617 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $36

HECTOR BANCHS MD

Cardiovascular Disease

29,255

$934K

1185
899 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$32
Average prescription price

Avg: $36

HECTOR MENDEZ-RIVERA MD

Cardiovascular Disease

28,631

$796K

1236
1101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$28
Average prescription price

Avg: $36

HECTOR COLOMBANY LORENZO M.D.

Cardiovascular Disease

28,032

$1.13M

1588
1173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $36

OSVALDO JIMENEZ-MERCADO M.D.

Cardiovascular Disease

26,298

$1.03M

746
682 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $36

ROBERTO PEREZ-GUTIERREZ M.D.

Cardiovascular Disease

23,793

$810K

1069
936 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $36

DENIS RUIZ-SERRANO MD

Cardiovascular Disease

21,974

$607K

1085
878 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$28
Average prescription price

Avg: $36

PEDRO PAEZ GONZALEZ MD

Cardiovascular Disease

20,914

$891K

885
706 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $36

ILDEFONSO RIVERA MD

Cardiovascular Disease

20,753

$918K

793
634 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $36

JOSE RIVERA IRIZARRY M.D.

Cardiovascular Disease

20,110

$697K

1682
1250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$35
Average prescription price

Avg: $36

JOSE MONTES-MERCADO M.D.

Cardiovascular Disease

20,057

$849K

1262
986 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $36

JOSE ACEVEDO

Cardiovascular Disease

18,878

$822K

1075
763 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $36

ANTONIO FIGUEROA RIVERA M.D.

Cardiovascular Disease

17,763

$558K

606
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$31
Average prescription price

Avg: $36

RIGOBERTO RAMOS GONZALEZ MD

Cardiovascular Disease

17,754

$606K

1029
806 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $36

JOSE RAMOS MD

Cardiovascular Disease

17,740

$749K

686
632 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $36

RAFAEL DELGADO MD

Cardiovascular Disease

17,682

$608K

1623
1174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $36

ROBERTO FRED MD FACC

Cardiovascular Disease

17,357

$547K

1186
985 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$32
Average prescription price

Avg: $36

JOSE RIVERA DEL RIO MD

Cardiovascular Disease

17,303

$613K

909
756 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$35
Average prescription price

Avg: $36

RAMON PEREA M.D.

Cardiovascular Disease

17,246

$607K

642
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$35
Average prescription price

Avg: $36

PABLO SERRANO M.D.

Cardiovascular Disease

16,925

$574K

724
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $36

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank